Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age-Reference-Cited by-同舟云学术

Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age

Published:2021-04-14 Issue:9 Volume:35 Page:1413-1421
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

MacBrayne Christine E.,Rutstein Richard M.,Wiznia Andrew A.,Graham Bobbie,Alvero Carmelita G.,Fairlie Lee,Lypen Kathryn,George Kathleen H.,Townley Ellen,Moye Jack,Costello Diane G.,Reding Christina A.,Barroso Hofer Cristina,Crauwels Herta M.,Woot de Trixhe Xavier,Tambuyzer Lotke,Vanveggel Simon,Opsomer Magda,Kiser Jennifer J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference17 articles.

1. Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy;Jittamala;Pediatr Infect Dis J,2009

2. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis;Arrive;Int J Epidemiol,2007

3. TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments;Vingerhoets;J Virol,2005

4. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1;Andries;Antimicrob Agents Chemother,2004

5. Pharmacokinetics and pharmacokinetic/pharmacodynamic relationships of etravirine in HIV-1-infected, treatment-experienced children and adolescents in PIANO;Kakuda;J Clin Pharmacol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current drugs for HIV-1: from challenges to potential in HIV/AIDS;Frontiers in Pharmacology;2023-10-26

2. The role of HIV-1 polymorphism in the pathogenesis of the disease;HIV Infection and Immunosuppressive Disorders;2023-10-21

3. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand;Antiviral Therapy;2022-06

4. Antiviral drugs;Side Effects of Drugs Annual;2022

5. Pediatric liquid ‘single tablet regimens’ for HIV—a call to action;AIDS;2021-07-15